Inhibitor Committee
Mandate
- To initiate clinical research on clotting factor inhibitor
- To serve as a resource for inhibitor research initiated by other members of the AHCDC or by the AHCDC Research Committee
- To advise members of AHCDC and other physicians in Canada in managing inhibitor patients, by the generation of guidelines or treatment recommendations as appropriate
In the committee
-
Dr. Paul Moorehead
Chair -
Dr. Jerome Teitel
Member -
Dr. David Lillicrap
Member -
Dr. Jean St-Louis
Member -
Dr. Natalia Rydz
Member -
Dr. Manuel Carcao
Member -
Dr. Davide Matino
Member -
Dr. Marie-Claude Pelland-Marcotte
Member -
Dr. Linda (Haowei) Sun
Member -
Dr. V. Bouskill
Member (External)